Supplement

Supplement

HTML

Characterising novel pathways to schizophrenia
Ian B Hickie and Patrick D McGorry — Med J Aust 2009; 190 (4): S5-S6.

HTML

New directions in the epidemiology of schizophrenia
John J McGrath and Ezra S Susser — Med J Aust 2009; 190 (4): S7-S9.

HTML

Brain changes during the onset of schizophrenia: implications for neurodevelopmental theories
Stephen J Wood, Christos Pantelis, Alison R Yung, Dennis Velakoulis and Patrick D McGorry — Med J Aust 2009; 190 (4): S10-S13.

HTML

Synapse formation and regression in the cortex during adolescence and in schizophrenia
Maxwell R Bennett — Med J Aust 2009; 190 (4): S14-S16.

HTML

Are common childhood or adolescent infections risk factors for schizophrenia and other psychotic disorders?
Ian B Hickie, Richard Banati, Catherine H Stewart and Andrew R Lloyd — Med J Aust 2009; 190 (4): S17-S21.

HTML

Amphetamine psychosis: a model for studying the onset and course of psychosis
Daniel F Hermens, Dan I Lubman, Philip B Ward, Sharon L Naismith and Ian B Hickie — Med J Aust 2009; 190 (4): S22-S25.

HTML

Therapeutic signposts: using biomarkers to guide better treatment of schizophrenia and other psychotic disorders
Richard Banati and Ian B Hickie — Med J Aust 2009; 190 (4): S26-S32.

HTML

A clinical trials agenda for testing interventions in earlier stages of psychotic disorders
Patrick D McGorry, Alison R Yung, Christos Pantelis and Ian B Hickie — Med J Aust 2009; 190 (4): S33-S36.

HTML

Oestrogen — a new treatment approach for schizophrenia?
Jayashri Kulkarni — Med J Aust 2009; 190 (4): S37-S38.

HTML

Are the cardiometabolic complications of schizophrenia still neglected? Barriers to care
Tim J R Lambert and John W Newcomer — Med J Aust 2009; 190 (4): S39-S42.

HTML

Mental health policy — stumbling in the dark?
David W Crosbie — Med J Aust 2009; 190 (4): S43-S45.

Home | Issues | eMJA shop | Terms of use | Classifieds | More... | Contact | Topics | Search

The Medical Journal of Australia    eMJA